Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
作者信息
Tilchen E J, Fleming T, Mills G, Oishi N, Bonnett J D, Natale R B, Harker G, Coltman C A
机构信息
Henry Ford Hospital, Detroit, MI.
出版信息
Cancer Treat Rep. 1987 Dec;71(12):1309-10.
PMID:3690548
Abstract
摘要
相似文献
1
Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
Cancer Treat Rep. 1987 Dec;71(12):1309-10.
2
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
Cancer Treat Rep. 1985 Jun;69(6):709-10.
3
Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study.重氮醌用于难治性和复发性多发性骨髓瘤患者的II期试验：一项西南肿瘤协作组研究
Cancer Treat Rep. 1987 Nov;71(11):1095-6.
4
Phase II trial of diaziquone in advanced renal adenocarcinoma.
Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1055-6.
5
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.重氮醌用于晚期软组织和骨肉瘤的II期研究：一项西南肿瘤协作组的研究
Cancer Treat Rep. 1985 Sep;69(9):1035-6.
6
7
8
Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Cancer Treat Rep. 1986 Feb;70(2):309-10.
9
Phase II study of diaziquone in patients with advanced carcinoma of the lung.
Cancer Treat Rep. 1984 Sep;68(9):1193-4.
10
Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):921-2.
引用本文的文献
1
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.金纳米粒子的制备用于胰腺癌的靶向治疗。
Adv Drug Deliv Rev. 2010 Mar 8;62(3):346-61. doi: 10.1016/j.addr.2009.11.007. Epub 2009 Nov 13.
Zotero 插件